BTB域和CNC同类2:控制免疫反应和癌症进展的主调节器
Chenyang Li1, Wei Lu2, Han Zhang1
1Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan 650118, China.
Biochimica et biophysica acta. Reviews on cancer
|April 19, 2025
概括
BTB域和CNC同源2 (BACH2) 是血液细胞发育和免疫力的关键调节者. 它作为瘤抑制剂和促进剂在各种癌症中的双重作用凸显了其复杂的参与和治疗潜力.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- BTB域和CNC同源2 (BACH2) 是一种转录抑制剂,参与血液学发育和免疫细胞分化.
- 在淋巴细胞中BACH2的表达强调了它在免疫调节中的重要性.
- BACH2在血液形成中的多方面的作用对于理解其在癌症中的影响至关重要.
研究的目的:
- 提供BACH2在血液形成中的演变作用的全面概述.
- 专注于BACH2与各种癌症类型之间的关联.
- 探索BACH2在瘤学中的治疗潜力.
主要方法:
- 关于BACH2的现有研究的文献综述2.
- 分析BACH2在血液形成的不同阶段的功能.
- 检查BACH2在瘤发生和癌症进展中的参与.
主要成果:
- BACH2在造血干细胞和原生细胞 (HSPC) 血统承诺和免疫细胞发育中发挥着关键作用.
- 有证据表明,BACH2主要作为瘤抑制剂起作用.
- 矛盾的发现表明,BACH2可能在特定情况下促进瘤发生,突出显示其复杂的网络相互作用.
结论:
- BACH2在血液形成和免疫中的复杂和上下文依赖的作用至关重要.
- 了解BACH2在癌症中的双重功能对于开发向疗法至关重要.
- 在一系列癌症类型中,BACH2具有显著的治疗潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


